vepacel
ology bioservices ireland ltd - influenza virus (whole virion, inactivated), containing antigen of: a/vietnam/1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenza vaccines - active immunisation against h5n1 subtype of influenza a virus. this indication is based on immunogenicity data from subjects from the age of 6 months onwards following administration of two doses of vaccine prepared with h5n1 subtype strains. vepacel should be used in accordance with official guidance.,
influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes
split virion, inactivated - influenza virus split virion - suspension for injection
influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes
split virion, inactivated - influenza virus split virion - suspension for injection
vanguard resp 3 intranasal live vaccine for dogs
zoetis australia pty ltd - bordetella bronshiseptica; canine adenovirus type 2; canine parainfluenza virus - misc. vaccines or anti sera - bordetella bronshiseptica active 0.0 cfu/ml; canine adenovirus type 2 vaccine-virus active 0.0 tci50/do; canine parainfluenza virus vaccine-viral active 0.0 tci50/do - immunotherapy
vanguard resp 2 intranasal live vaccine for dogs
zoetis australia pty ltd - bordetella bronshiseptica; canine parainfluenza virus - misc. vaccines or anti sera - bordetella bronshiseptica active 0.0 p; canine parainfluenza virus vaccine-viral active 0.0 p - immunotherapy
optaflu
seqirus gmbh - influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:a/california/7/2009 (h1n1)pdm09 - like strain(a/brisbane/10/2010, wild type)a/switzerland/9715293/2013 (h3n2) - like strain(a/south australia/55/2014, wild type)b/phuket/3073/2013–like strain(b/utah/9/2014, wild type) - influenza, human; immunization - vaccines - prophylaxis of influenza for adults, especially in those who run an increased risk of associated complications.optaflu should be used in accordance to official guidance.
protech bronchi-shield iii bordetella bronchiseptica, canine adenovirus type 2 and parainfluenza vaccine
boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; bordetella bronchiseptica; canine adeno virus type 2 - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 p; bordetella bronchiseptica vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p - immunotherapy - dog - over 8 weeks - bordetella bronchiseptica | canine adenovirus - type 2 | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis
pandemic influenza vaccine h5n1 baxter (whole virion, vero cell derived, inactivated) suspension for injection 0.5 ml dose
au pharma pty ltd - influenza virus haemagglutinin, quantity: 15 microgram/ml - injection, suspension - excipient ingredients: trometamol; water for injections; sodium chloride; polysorbate 80 - pandemic influenza vaccine h5n1 baxter is indicated for prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official recommendations.
panvax h1n1 vaccine
seqirus (nz) ltd - influenza virus a/california/7/2009 (h1n1) - like strain 15ug - suspension for injection - 15 mcg/0.5ml - active: influenza virus a/california/7/2009 (h1n1) - like strain 15ug excipient: calcium chloride dihydrate dibasic sodium phosphate monobasic potassium phosphate monobasic sodium phosphate dihydrate potassium chloride sodium chloride thiomersal water for injection - for active immunisation to prevent influenza disease caused by the influenza a(h1n1) virus, in adults, adolescents and children 10 years of age and older.
agrippal s1 influenza vaccine
seqirus pte. ltd. - influenza virus (sh) a/california/07/2009 (h1n1) pdm09- like strain; influenza virus (sh) a/hong kong/4801/2014 (h3n2) - like strain; influenza virus (sh) b/brisbane/60/2008 - like strain - injection - 15 mcg ha/0.5ml - influenza virus (sh) a/california/07/2009 (h1n1) pdm09- like strain 15 mcg ha/0.5ml; influenza virus (sh) a/hong kong/4801/2014 (h3n2) - like strain 15 mcg ha/0.5ml; influenza virus (sh) b/brisbane/60/2008 - like strain 15 mcg ha/0.5ml